SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility, prompting discussions about a potential market correction or even the start of a bear market. Fed Governor Lisa Cook's comments regarding high valuations are being cited as a possible catalyst for the downturn. Community sentiment is mixed, with both bulls and bears actively trading the volatility and debating potential bottom levels and future direction.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Despite strong earnings, NVIDIA is experiencing a sell-off, leading to widespread discussion about potential market manipulation and whether the AI bubble is bursting. Community sentiment is largely negative, with many questioning the high valuations and pointing to potential downside. Some traders are expressing frustration, while others are seizing the opportunity to buy the dip or profit from short positions.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing significant volatility as traders react to a strong earnings report from NVDA and monitor key economic data, including jobs numbers. Community members are actively debating whether recent market movements signal a continuation of the uptrend or a potential bull trap. Discussions also focus on the possibility of future Fed rate cuts and their potential impact on the technology sector.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending downwards, sparking debate about potential support levels and whether this signals the end of the current cycle. Community members are discussing Michael Saylor's position and potential liquidations, while others point to broader market factors and potential manipulation. The conversation includes opinions on Bitcoin's role as a store of value and its impact on the wider market.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending downwards as it amplifies Bitcoin's movements, with concerns rising about debt leverage and potential liquidation. Community discussions revolve around whether the stock is overvalued and how much further it could drop, with some anticipating a significant decline. Broader market commentary suggests potential risks tied to hedge fund activity and overall market valuations which may impact Strategy.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community debates its future amidst market volatility and the launch of new ETFs; traders are actively discussing potential price floors and whether upcoming events will act as catalysts. Community members are split on whether to buy the dip or brace for further declines, while some question XRP's utility and its correlation with Bitcoin's price movements.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending amid a broader tech sector pullback and ahead of Nvidia's earnings report, with some traders expressing concerns about an AI bubble. The community is debating whether the dip presents a buying opportunity or if further declines are expected, while others are highlighting AMD's partnerships and potential for growth in the AI space. Discussions also include potential price targets and the impact of macroeconomic factors on the stock's performance.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending as rising memory prices, driven by AI data-center demand, spark bullish sentiment and debate over whether the stock is overbought. The community is weighing strong growth prospects against potential short-term pullbacks after a significant year-to-date rally. Recent analyst upgrades and reports of supply constraints are also contributing to the increased interest in $MU.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings Corp is trending due to a shift in business strategy and community speculation around a potential short squeeze. Traders are actively debating float size, short interest, and the possibility of a GME-like scenario, while others express concerns about pump-and-dump schemes and dilution. High volatility and trading volume contribute to the ongoing discussion.

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending downwards as investors express concerns about the company's performance, linking it to Ethereum's price struggles and broader crypto market volatility. The community is actively discussing potential support levels, the impact of unrealized losses on ETH holdings, and the effectiveness of the company's accumulation strategy. Some investors are questioning the credibility of bullish forecasts and expressing frustration with the stock's recent performance.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Esperion’s stock (ESPR) has risen 40.5% so far in 2025. (Representative Image: Getty Images)

Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position

The firm alleged that Praxis “gamed” the data from its late-stage trial of Ulixacaltamide in essential tremor.

Equity

<ul class="summary-bullets"><li>The company said the probe identified issues in its financial reporting and that it had restated its previously issued financial statements.</li><li>PACS now expects core profit for the full year to be in the range of $480 million to $490 million, above an $472.72 million expected by analysts.&nbsp;</li><li>Revenue for the full year is expected to be in the range of $5.25 billion to $5.35 billion.</li></ul>Shares of PACS Group, Inc. (PACS) jumped 53% in the pre-market session on Thursday after the company said that an audit committee had completed its independent investigation into the allegations made by short seller Hindenburg Research in its report in November 2024.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.pacs.com/news-events/press-releases/detail/121/pacs-group-inc-reports-third-quarter-2025-results">said </a>that the recommendations by the committee have been or are being implemented. The company said that the probe identified issues within its financial reporting and restated its previously issued financial statements, including a $46.1 million reduction in the revenue reported for the three-month period ended June 30, 2024.“...today is the start of a new chapter for PACS,” said CEO Jason Murray in a call with analysts on Wednesday while reiterating efforts to build trust with stakeholders.<h2 class="st-heading-2">Outlook For The Year Ahead</h2>The company now expects core profit for the full year to be in the range of $480 million to $490 million, above the $472.72 million expected by analysts, according to data from Fiscal AI.Revenue for the full year is expected to be in the range of $5.25 billion to $5.35 billion, up from an expected $4.6 billion.<h2 class="st-heading-2">Q3 Earnings</h2>The company reported third quarter revenue of $1.34 billion, an increase of 31.0% over prior year, and above an estimated $949.48 million.Core profit for the three months was $131.5 million, above an estimated $85.90 million.PACS Group is a holding company investing in post-acute healthcare facilities. Its units operate 320 care facilities across 17 states.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around PACS stayed within the ‘extremely bullish’ territory over the past 24 hours while message volume remained at ‘extremely high’ levels. However, retail sentiment around PACS hit its highest levels this year on Thursday.<figure class="image"><img style="aspect-ratio:623/60;" src="data:image/png;base64,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" width="623" height="60" alt="PACS’s Sentiment Meter and Message Volume as of 9:15 a.m. ET on Nov. 20, 2025 | Source: Stocktwits"><figcaption>PACS’s Sentiment Meter and Message Volume as of 9:15 a.m. ET on Nov. 20, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/PACS">PACS stock</a> is up by 28% this year and down by about 2% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-urges-china-customers-to-buy-model-y-inventory-as-wait-time-for-custom-orders-stretch-into-2026/cLPAi4CRE9U">Tesla Urges China Customers To Buy Model Y Inventory As Wait Time For Custom Orders Stretch Into 2026</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, a PACS Group company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

PACS Group Stock Soars Premarket On Completion Of Audit Committee Probe, Upbeat Full-Year Guidance

The company said the committee's recommendations have been or are being implemented.

<ul class="summary-bullets"><li>The company said that there can be no assurance that the strategic alternatives review will result in the company pursuing a transaction or any specific outcome.&nbsp;</li><li>Atkore added that no deadline or definitive timetable had been set for the completion of the strategic alternatives review.</li><li>The company also announced it will appoint Franklin Edmonds to its board as part of a cooperation agreement with Irenic Capital Management LP.&nbsp;</li></ul>Atkore Inc. (ATKR) said on Thursday that its board has expanded the scope of its previously announced review of strategic alternatives to include assets outside its core electrical infrastructure portfolio and to explore a potential sale or merger of the whole company.“As the Board conducts its expanded strategic review process, management will continue to take actions to strengthen the business, including focusing on our core electrical infrastructure business and improving our cost structure to drive profitable growth,” said Atkore’s Chairman of the Board.CEO Bill Waltz noted that, given the board’s decision to expand the strategic alternatives process, he has decided to stay on as CEO through at least the conclusion of the strategic review.<h2 class="st-heading-2">Detail On The Strategic Alternatives</h2>The company said that there can be no assurance that the strategic alternatives review will result in the company pursuing a transaction or any specific outcome. “There is no deadline or definitive timetable set for completion of the strategic alternatives review,” Atkore said.Atkore also announced it will appoint Franklin Edmonds to its board as part of a cooperation agreement with Irenic Capital Management LP. The company added that the board will form a Strategic Review Committee to oversee, evaluate, and provide advice to the full board.<h2 class="st-heading-2">What Is Retail Thinking?</h2>Retail sentiment on Atkore jumped to ‘bullish’ from ‘neutral’ territory compared to a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.<a href="https://stocktwits.com/symbol/ATKR">Shares of Atkore</a> have declined by more than 20% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-gap-stock-rising-in-premarket-today/cLPAX5zRE9o">Why Is Gap Stock Rising In Premarket Today?</a>

Representative image of a trending stock chart.

Atkore Expands Review Process: CEO To Stay On As It Explores Sale Or Merger Options 

Bill Waltz noted that, given the board’s decision to expand the strategic alternatives process, he has decided to stay on as CEO.

<ul class="summary-bullets"><li>The company said that the late-stage study of Mitapivat in patients with sickle cell disease met the primary endpoint of hemoglobin response.&nbsp;</li><li>The drug also yielded positive outcomes on change from baseline in hemoglobin concentration and indirect bilirubin levels compared with placebo.&nbsp;</li><li>While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises compared to placebo, this trend did not achieve statistical significance, the company noted.</li></ul>Shares of Agios Pharmaceuticals, Inc. (AGIO) slumped 48% on Wednesday after the company reported mixed results from its drug trial in sickle cell disease.Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage. The condition leads to complications like painful episodes or crises, anemia, infections, stroke, and damage to organs.<h2 class="st-heading-2">What Did The Study Show?</h2>The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/19/3190791/31990/en/Agios-Announces-Topline-Results-from-RISE-UP-Phase-3-Trial-of-Mitapivat-in-Sickle-Cell-Disease.html">said</a> that the late-stage study of Mitapivat in patients aged 16 years and older with sickle cell disease met the primary endpoint of hemoglobin response, with the drug demonstrating a statistically significant improvement compared to placebo. Hemoglobin response is defined as an increase from baseline in average hemoglobin by more than or equal to 1.0 g/dL.The drug also showed positive effects on changes from baseline in hemoglobin concentration and indirect bilirubin levels compared with placebo.While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises (SCPCs) or acute pain needing medical contact compared to placebo, this trend did not achieve statistical significance, the company noted. Further, there were no improvements from baseline on fatigue scores among patients, the company noted.The firm now expects to share the comprehensive results from the clinical program with the FDA in the first quarter of 2026 and seek potential U.S. regulatory approval.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AGIO">AGIO stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.AGIO stock is down by 28% this year and by 57% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/kzia-stock-soars-after-company-stage-iv-cancer-patients-shows-initial-complete-remission-on-its-drug-combination/cLPoQdMREBN">KZIA Stock Soars After Stage IV Cancer Patient Shows Initial Complete Remission On Its Drug Combination</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Agios Pharmaceuticals logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial 

 Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage.

<ul class="summary-bullets"><li>Joby noted that the sandbox will serve as a base for evaluating potential air taxi operations in the region.</li><li>Saudi Arabia joins the U.S., the U.K., Japan, South Korea and the UAE as another key launch market for Joby's air taxi service.</li><li>In September, the company announced a long-term collaboration with the Ras Al Khaimah Transport Authority and Skyports Infrastructure to launch a passenger air taxi service network in the Emirate of Ras Al Khaimah by 2027.</li></ul>Joby Aviation (JOBY) said on Wednesday it has signed a memorandum of understanding with Red Sea Global and The Helicopter Company that includes plans for Joby to complete pre-commercial evaluation flights of its electric air taxi in Saudi Arabia in the first half of 2026.The company said that under the agreement, Joby will work together with Red Sea Global, the developer behind regenerative tourism destinations The Red Sea and AMAALA, and The Helicopter Company, a Public Investment Fund company and Saudi Arabia’s commercial helicopter operator, to establish a "sandbox" for pre-commercial operations.Joby noted that the sandbox will serve as a base for evaluating potential air taxi operations in the region, with Joby conducting representative flights that include charging, airspace integration, and ground communications, similar to the flights it completed in the UAE earlier this year.Shares of Joby, which develops electric air taxis for commercial passenger service, were up nearly 2% in premarket trading.<h2 class="st-heading-2">Use Of FAA Certification</h2>The new partnership announced on Wednesday comes following Joby's announcement last week that it would collaborate with the General Authority of Civil Aviation (GACA) to support the development of the Kingdom's air taxi regulatory framework, using Federal Aviation Administration (FAA) certification standards as a foundation.According to a new memorandum of understanding with GACA, Joby will use FAA certification standards as a foundation to create a streamlined approval process for Joby’s aircraft in Saudi Arabia. Saudi Arabia joins the U.S., the U.K., Japan, South Korea and the UAE as another key launch market for Joby's air taxi service.<h2 class="st-heading-2">Joby’s Expansion In The Middle East</h2>In September, the company announced a long-term collaboration with the Ras Al Khaimah Transport Authority and Skyports Infrastructure to launch a passenger air taxi service network in the Emirate of Ras Al Khaimah by 2027.Joby had noted that as part of a six-year exclusive agreement, the company is also planning to start air taxi operations in Dubai in 2026. Joby, in November, said that the company signed a letter of intent to sell aircraft and services valued at up to $250 million to Alatau Advance Air Group dedicated to introducing air taxis to Kazakhstan.Retail sentiment on Joby remained unchanged in the ‘bearish’ territory, with message volumes at ‘low’ levels, according to data from Stocktwits.<a href="https://stocktwits.com/symbol/JOBY">Shares of Joby</a> have gained nearly 125% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nokia-restructures-operations-into-network-and-mobile-infrastructure-segments-as-company-focuses-on-ai/cLPoIMyREBT">Nokia Restructures Operations Into Network And Mobile Infrastructure Segments As Company Focuses On AI</a>

ANA Holdings and Joby Aviation show a public demonstration flight of the Joby N5.42JX flying car at the World Expo 2025 Osaka on October 13, 2025 in Osaka, Japan.

Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia

The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations.

<ul class="summary-bullets"><li>In the initial phase of the agreement, Archer Aviation will work with The Helicopter Company as well as RSG to help build the foundational framework for its planned eVTOL operations in Saudi Arabia.</li><li>After the testing program, the parties involved will review the results and consider further initiatives for large-scale introduction of eVTOL services, they said.</li></ul> Archer Aviation Inc. (ACHR) has inked a deal with The Helicopter Company to bring their Midnight air taxi to the Kingdom of Saudi Arabia in partnership with Red Sea Global (RSG), the eVTOL maker said on Wednesday.The partnership <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.investors.archer.com/news/news-details/2025/PIFs-The-Helicopter-Company-Archer-Aviation-and-Red-Sea-Global-Partner-to-Launch-eVTOL-Air-Mobility-in-Saudi-Arabia/default.aspx">will focus</a> on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations as one of the first deployments of eVTOL aircraft in the Kingdom of Saudi Arabia.<h2 class="st-heading-2">How Will The Partnership Work?</h2>While The Helicopter Company is a Saudi Public Investment Fund company and commercial helicopter operator, Red Sea Global (RSG), is the real estate developer behind regenerative tourism destinations The Red Sea and AMAALA.In the initial phase of the agreement, Archer Aviation will work with The Helicopter Company as well as RSG to help build the foundational framework for their planned eVTOL operations in Saudi Arabia, including the establishment of an environment to conduct test flights with Archer’s Midnight eVTOL under real-world conditions.As the partnership progresses, RSG will lead testing with Archer’s Midnight aircraft to evaluate the potential to integrate eVTOL aircraft into the company’s future operations.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/ACHR">ACHR shares</a> rose 1% in the pre-market session at the time of writing. On Stocktwits, retail sentiment around ACHR jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.ACHR stock is down by 22% this year and up by about 48% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/alkermes-to-acquire-avadel-for-up-to-2.37-billion-after-lundbeck-proposal/cLPoIyoREB2">Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Archer Aviation logo is displayed on a smartphone screen. (Photo by Cheng Xin/Getty Images)

Archer Aviation Lands Partnership To Deploy Air Taxi In Saudi Arabia

The partnership will focus on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations. 

In this photo illustration, the Scholar Rock Holding logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Did Scholar Rock Soar 26% Today?

The company is planning to reapply for approval of a muscle atrophy therapy in the coming year. 

<ul class="summary-bullets"><li>The report stated that private equity firm Leonard Green had previously acquired a minority stake in Topgolf.</li><li>Last year, Topgolf Callaway Brands announced its intention to pursue the separation of its business into two independent companies.</li><li>The company had then said that it expects to effect the separation through a spin-off of the Topgolf business.</li></ul>Topgolf Callaway Brands (MODG) stock rose nearly 5% after the company reportedly entered into discussions with private-equity firm Leonard Green to sell its Topgolf unit.According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion. The report added that Leonard Green had previously acquired a minor stake in Topgolf.<h2 class="st-heading-2">Topgolf Callaway Brands Separation</h2>This report comes more than a year after Topgolf Callaway Brands announced its intention to separate its business into two independent companies: Callaway, a golf equipment company with an activewear business, and Topgolf, a golf entertainment business.The company had then said that it expects to effect the separation through a spin-off of the Topgolf business. While the firm had stated that it expects a spin-off of Topgolf into a stand-alone public company to be the most likely separation path, it also noted that it would continue to evaluate other options for separation.<h2 class="st-heading-2">How Did Retail Users React?</h2>Retail sentiment on <a href="https://stocktwits.com/symbol/MODG">Topgolf Callaway Brands</a> dipped to ‘bullish’ from ‘extremely bullish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.Shares of the company have gained nearly 45% this year and increased by 33% over the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/doug-mcmillon-to-retire-from-walmart-in-january-john-furner-to-succeed/cLPQO3ZRE4f">Doug McMillon To Retire From Walmart In January, John Furner To Succeed As CEO</a>

Topgolf Callaway Brands Jumps 5% After Report Says Talks Are On To Sell Topgolf Unit

According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion.

<ul class="summary-bullets"><li>Under the deal, Merck will buy Cidara for $221.50 per share in cash through a unit.</li><li>The purchase price represents a premium of about 109% from CDTX’s closing price on Thursday.</li></ul>Merck (MRK) said on Friday that it has entered into a definitive agreement to acquire Cidara Therapeutics (CDTX) for about $9.2 billion.Under the deal, Merck will buy Cidara for $221.50 per share in cash through a unit. The purchase price represents a premium of about 109% from CDTX’s closing price on Thursday. The <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.merck.com/news/merck-to-acquire-cidara-therapeutics-inc-diversifying-its-portfolio-to-include-late-phase-antiviral-agent/">transaction</a> is expected to close in the first quarter of 2026, subject to the satisfaction of certain conditions.<h2 class="st-heading-2">What Does The Deal Bring For Merck?</h2>The takeover marks Merck’s latest move to fortify its drug portfolio before Keytruda, its $25 billion-per-year cancer therapy, loses patent protection in 2028. The company agreed in July to buy respiratory drug developer Verona Pharma for $10 billion as part of a broader effort to maintain revenue momentum.With the new deal, Merck would gain access to Cidara’s lead candidate CD388 designed to prevent influenza infection in individuals at higher risk of influenza complications. CD388 has been granted a breakthrough designation by the U.S. Food and Drug Administration, which could accelerate regulatory approval.The treatment is currently being evaluated in a late-stage trial among both adult and adolescent participants who are at higher risk of developing complications from influenza. The trial is expected to enroll 6000 participants by December, the company said earlier this month.“This acquisition expands and complements our respiratory portfolio and pipeline. Influenza continues to pose a significant global health threat, causing widespread illness, morbidity and death each year especially in older adults and immunocompromised individuals, such as those with cancer and chronic diseases,” said Dr. Dean Y. Li, President, Merck Research Laboratories.The deal has been approved by the board of directors of both companies, Merck said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2><a href="https://stocktwits.com/symbol/CDTX">CDTX shares</a> jumped 105% in the premarket session at the time of writing, while <a href="https://stocktwits.com/symbol/MRK">MRK shares</a> fell over 1%. On Stocktwits, retail sentiment around CDTX jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘extremely high’ levels.CDTX stock has nearly quadrupled in value this year, while MRK shares have fallen 7%.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/avxl-shares-slump-pre-market-after-ema-committee-fails-to-recommend-approval-for-alzheimers-drug/cLPQ7tkRE4E">AVXL Shares Slump Pre-Market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Cidara Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio

With the new deal, Merck would gain access to CD388, currently in late-stage development, and designed to prevent influenza infection in individuals at higher risk of influenza complications. 

<ul class="summary-bullets"><li>CHMP provides recommendations to the EMA on human medicines, which the agency uses to approve or reject a drug.</li><li>However, the drug didn’t feature on the list of medicines for which applications were withdrawn following a meeting with the committee.&nbsp;</li><li>Anavex confirmed on Friday that it was informed by the CHMP of a negative trend vote on its application for Blarcamesine following its oral explanation.</li></ul>Shares of Anavex Life Sciences (AVXL) slumped 45% in the premarket session on Friday after a European Medicines Agency (EMA) committee did not recommend a much-awaited approval for the company’s Alzheimer’s drug Blarcamesine.Retail investors were looking forward to the Committee for Medicinal Products for Human Use’s opinion on the drug after it placed Blarcamesine on its agenda for oral explanations and regulatory review during the session scheduled from Nov. 10 to Nov.13, with the oral explanation held behind closed doors on Nov. 11.<h2 class="st-heading-2">CHMP Avoids Recommendation For Blarcamesine</h2>The CHMP <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-10-13-november-2025">released</a> its meeting highlights on Friday and recommended approval for ten new medicines, but Blarcamesine did not feature on the list. CHMP provides recommendations to the EMA on human medicines, which the agency uses to approve or reject a drug. The lack of a positive recommendation dampens chances for an EMA approval for the drug.However, the drug also didn’t feature on the list of medicines for which applications were withdrawn following a meeting with the committee.Anavex <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/14/3188222/29248/en/Anavex-Life-Sciences-Provides-Regulatory-Update-on-Blarcamesine-for-Early-Alzheimer-s-Disease.html">confirmed</a> on Friday that it was informed by the CHMP of a negative trend vote on its application for Blarcamesine following its oral explanation. The committee is expected to adopt a formal opinion on the application at its December meeting, the company said, while adding that it intends to request a re-examination of the committee’s opinion.Anavex submitted an application to the EMA for Blarcamesine in November 2024 based on data from a Phase 2b/3 trial, and the agency subsequently accepted it in December. If the application is approved, it would allow Blarcamesine to be marketed in all EU member states.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around<a href="https://stocktwits.com/symbol/AVXL"> AVXL stock </a>stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.AVXL stock is down 47% this year and by 29% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/avadel-gets-acquisition-proposal-from-lundbeck-weeks-after-inking-agreement-with-alkermes/cLPQetHRE4T">Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

AVXL Shares Slump Pre-Market After EMA Committee Fails To Recommend Approval For Alzheimer’s Drug

The CHMP released its meeting highlights on Friday and recommended approval for ten new medicines, but Blarcamesine was not included in the list.

Current Price	$38.55
Prev Close	$38.85
Open	$39.35
Dividend Yield	N/A
50-Day Moving Average	$40.53
Beta	N/A
Avg. Volume	9,333.13
PE Ratio	N/A

52-Week High	$49.18
52-Week Low	$34.29
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IWMW
iShares Russell 2000 BuyWrite ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWMW News

IWMWiShares Russell 2000 BuyWrite ETF